Smart healthcare: Artificial intelligences impact on drug development and patient care

Sachin Mendhi , Krutika Sawarkar , Amruta Shete , Kuldeep Vinchurkar , Sachin S. Mali , Sudarshan Singh , Pooja V. Nagime

Intelligent Pharmacy ›› 2025, Vol. 3 ›› Issue (3) : 225 -234.

PDF (2211KB)
Intelligent Pharmacy ›› 2025, Vol. 3 ›› Issue (3) : 225 -234. DOI: 10.1016/j.ipha.2025.01.003
Review article

Smart healthcare: Artificial intelligences impact on drug development and patient care

Author information +
History +
PDF (2211KB)

Abstract

The integration of artificial intelligence (AI) into healthcare has catalyzed significant advancements in drug development and patient care, revolutionizing traditional methodologies. This review explores the multifaceted impact of AI on critical areas, highlighting its transformative potential and addressing associated challenges. In drug development, AI facilitates accelerated discovery processes, enhances precision in predicting drug efficacy and safety, and optimizes clinical trial designs. AI-driven technologies such as machine learning (ML) algorithms and deep learning models enable the analysis of vast datasets, leading to the identification of novel therapeutic targets and personalized treatment strategies. In patient care, AI enhances diagnostic accuracy, enables predictive analytics for disease management, and supports telemedicine as well as remote monitoring, thereby improving patient outcomes and accessibility to healthcare services. Despite the promising advancements, the review critically examines the ethical, regulatory, and implementation challenges that accompany AI integration in healthcare. By providing a comprehensive overview of AI's current and potential contributions, this paper aims to provide an elaborative guide that future research and policymaking in smart healthcare.

Keywords

Artificial intelligence / Drug development / Patient care / Machine learning / Telemedicine

Cite this article

Download citation ▾
Sachin Mendhi, Krutika Sawarkar, Amruta Shete, Kuldeep Vinchurkar, Sachin S. Mali, Sudarshan Singh, Pooja V. Nagime. Smart healthcare: Artificial intelligences impact on drug development and patient care. Intelligent Pharmacy, 2025, 3(3): 225-234 DOI:10.1016/j.ipha.2025.01.003

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Rayhan A , Rayhan R , Rayhan S , of HR. The role of AI in healthcare: revolutionizing patient care and well-being. Available from: www.researchgate.net/publication/372726962; 2023.

[2]

Prajapati JB , Kumar A , Singh S , et al. Artificial intelligence-assisted generative pretrained transformers for applications of ChatGPT in higher education among graduates. SN Social Sciences. 2024Jan 15; 4(2): 19.

[3]

Rathod SM , Patel NC , Prajapati BG , Prajapati JB , Singh S . Artificial intelligence issues. In: Agrawal Deepshikha, Tripathi Khushboo, Krishen Kumar, eds. Concepts of Artificial Intelligence and its Application in Modern Healthcare Systems. Boca Raton: CRC Press, Tayloer and Francise Group; 2023Jul 31: 213.

[4]

Kolluri S , Lin J , Liu R , Zhang Y , Zhang W . Machine learning and artificial intelligence in pharmaceutical research and development: a review. AAPS J[Internet]. 2022; 24 (1): 1- 10.

[5]

Kumar M , Alen J . The scope and applications of artificial intelligence in the medical sector. J Biomed Sustain Healthc Appl. 2021; 1 (1): 18- 25.

[6]

Gallego V , Naveiro R , Roca C , Ríos Insua D , Campillo NE . AI in drug development: a multidisciplinary perspective. Mol Divers[Internet]. 2021; 25 (3): 1461- 1479.

[7]

Blanco-González A , Cabezón A , Seco-González A , et al. The role of AI in drug discovery: challenges, opportunities, and strategies. Pharmaceuticals. 2023; 16 (6): 1- 11.

[8]

Maguire P , Speder B , Tremble L . Artificial intelligence in drug discovery. Regul Rapp. 2024; 21 (1).

[9]

Chen W , Liu X , Zhang S , Chen S . Artificial intelligence for drug discovery: resources, methods, and applications. Mol Ther Nucleic Acids. 2023; 31 (March): 691- 702.

[10]

Singh S , Kumar R , Payra S , Singh SK . Artificial intelligence and machine learning in pharmacological research: bridging the gap between data and drug discovery. Cureus. 2023; 15 (8).

[11]

Badwan BA , Liaropoulos G , Kyrodimos E , Skaltsas D , Tsirigos A , Gorgoulis VG . Machine learning approaches to predict drug efficacy and toxicity in oncology. Cell Reports Methods. 2023; 3 (2): 100413.

[12]

Dara S , Dhamercherla S , Jadav SS , Babu CM , Ahsan MJ . Machine learning in drug discovery: a review. In: Artificial Intelligence Review. Netherlands: Springer; 2022: 1947- 1999.

[13]

EDITDeepPharmaIntelligence . For Drug Discovery. Biomarker development and advanced R&D landscape overview 2020 ai startups-240 corporations-90 R&D centers-35 investors-600. www.deep-pharma.tech.DeepPharmaIntell; 2020. www .deep-pharma.tech.

[14]

Sharma A , Lysenko A , Jia S , Boroevich KA , Tsunoda T . Advances in AI and machine learning for predictive medicine. J Hum Genet. 2024: 1- 11.

[15]

Pun FW , Ozerov IV , Zhavoronkov A . AI-powered therapeutic target discovery. Trends Pharmacol Sci[Internet]. 2023; 44 (9): 561- 572.

[16]

Schuff N . MRI in clinical trials. Magn Reson Imaging Mov Disord A Guid Clin Sci. 2006: 264- 270.

[17]

Zhang B , Zhang L , Chen Q , Jin Z , Liu S , Zhang S . Harnessing artificial intelligence to improve clinical trial design. Commun Med. 2023; 3 (1): 8- 10.

[18]

Chopra H , Annu Shin DK , Munjal K , Priyanka Dhama K , et al. Revolutionizing clinical trials: the role of AI in accelerating medical breakthroughs. Int J Surg. 2023; 109 (12): 4211- 4220.

[19]

Shiwlani A , Khan M , Mannan A , Sherani K , Qayyum MU , Hussain HK . Revolutionizing healthcare: the impact of artificial intelligence on patient care, diagnosis, and treatment. JurnalmahasiswaCom. 2024; 1 (5): 779- 790.

[20]

Kim HE , Kim HH , Han BK , et al. Changes in cancer detection and false-positive recall in mammography using artificial intelligence: a retrospective, multireader study. Lancet Digit Heal. 2020; 2 (3): e138- e148.

[21]

van den Heuvel TLA , van der Eerden AW , Manniesing R , et al. Automated detection of cerebral microbleeds in patients with Traumatic Brain Injury. NeuroImage Clin. 2016; 12: 241- 251.

[22]

Oren O , Gersh BJ , Bhatt DL . Artificial intelligence in medical imaging: switching from radiographic pathological data to clinically meaningful endpoints. Lancet Digit Heal. 2020; 2 (9): e486- e488.

[23]

Bello GA , Dawes TJW , Duan J , et al. Deep-learning cardiac motion analysis for human survival prediction. Nat Mach Intell. 2019; 1 (2): 95- 104.

[24]

Park VY , Han K , Seong YK , et al. Diagnosis of thyroid nodules: performance of a deep learning convolutional neural network model vs. Radiologists. Sci Rep. 2019; 9 (1): 1- 9.

[25]

Stadlmann C , Zehetner A . Comparing AI-based and traditional prospect generating methods. J Promot Manag. 2022; 28 (2): 160- 174.

[26]

Hartmann NN , Wieland H , Vargo SL . Converging on a new theoretical foundation for selling. J Mark. 2018; 82 (2): 1- 18.

[27]

D'Haen J , Van Den Poel D , Thorleuchter D , Benoit DF . Integrating expert knowledge and multilingual web crawling data in a lead qualification system. Decis Support Syst. 2016; 82: 69- 78.

[28]

Maxville V , Lam CP , Armarego J . Learning to Select Software Components. 2004.

[29]

Taherdoost H , Madanchian M . AI advancements: comparison of innovative techniques. Artificial Intelligence. 2024; 5 (1): 38- 54.

[30]

Sheng JQ , Hu PJH , Liu X , Huang TS , Chen YH . Predictive analytics for care and management of patients with acute diseases: deep learning-based method to predict crucial complication phenotypes. J Med Internet Res. 2021; 23 (2).

[31]

Basile AO , Ritchie MD . Expert review of molecular diagnostics informatics and machine learning to define the phenotype. Expert Rev Mol Diagn. 2018; 00 (00): 1- 8.

[32]

Bahado-Singh RO , Vishweswaraiah S , Aydas B , et al. Precision cardiovascular medicine: artificial intelligence and epigenetics for the pathogenesis and prediction of coarctation in neonates. J Matern Neonatal Med. 2022; 35 (3): 457- 464.

[33]

Corral-Acero J , Margara F , Marciniak M , et al. The "Digital Twin" to enable the vision of precision cardiology. Eur Heart J. 2020; 41 (48): 4556- 4564B.

[34]

Karatzia L , Aung N , Aksentijevic D . Artificial intelligence in cardiology: hope for the future and power for the present. Front Cardiovasc Med. 2022; 9 (October): 1- 22.

[35]

Vuorinen AL , Leppänen J , Kaijanranta H , et al. Use of home telemonitoring to support multidisciplinary care of heart failure patients in Finland: randomized controlled trial. J Med Internet Res. 2014; 16 (12).

[36]

Naik N , Hameed BMZ , Shetty DK , et al. Legal and ethical consideration in artificial intelligence in healthcare: who takes responsibility? Front Surg. 2022; 9 (March): 1- 6.

[37]

Gupta R , Srivastava D , Sahu M , Tiwari S , Ambasta RK , Kumar P . Artificial intelligence to deep learning: machine intelligence approach for drug discovery. In: Molecular Diversityvol. 25.

[38]

Zhu J , Wang J , Wang X , et al. Prediction of drug efficacy from transcriptional profiles with deep learning. Nat Biotechnol. 2021; 39 (11): 1444- 1452.

[39]

Ali T , Ahmed S , Aslam M . Artificial intelligence for antimicrobial resistance prediction: challenges and opportunities towards practical implementation. Antibiotics. 2023; 12 (3).

[40]

Prasad K , Kumar V . Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2. Curr Res Pharmacol Drug Discov. 2021; 2 (July): 100042.

[41]

Andrés C , Caracas B , Advantage Q . AI in healthcare: revolutionizing patient care with predictive analytics and decision support systems josé gabriel carrasco ramírez introduction. Methodology. 2024; 1 (11).

[42]

Çelik IN , Arslan FK , Tun R , Yildiz I . Artificial intelligence on drug discovery and development. Ankara Univ Eczac Fak Derg. 2022; 46 (2): 400- 427.

[43]

Gerke S , Minssen T , Cohen G . Ethical and legal challenges of artificial intelligencedriven healthcare. Artificial Intelligence in Healthcare. 2020: 295- 336.

[44]

Rodrigues R . Legal and human rights issues of AI: gaps, challenges and vulnerabilities. J Responsible Technol. 2020; 4: 100005.

[45]

Morley J , Machado CCV , Burr C , et al. The ethics of AI in health care: a mapping review. Soc Sci Med. 2020; 260 (July).

[46]

Rezaie J , Feghhi M , Etemadi T . A review on exosomes application in clinical trials: perspective, questions, and challenges. Cell Commun Signal. 2022; 20 (1): 1- 13.

[47]

Poalelungi DG , Musat CL , Fulga A , et al. Advancing patient care: how artificial intelligence is transforming healthcare. J Pers Med. 2023; 13 (8): 1214.

[48]

Bajwa J , Munir U , Nori A , Williams B . Artificial intelligence in healthcare: transforming the practice of medicine. Futur Healthc J[Internet]. 2021; 8 (2): e188- e194.

[49]

Lambert SI , Madi M , Sopka S , et al. An integrative review on the acceptance of artificial intelligence among healthcare professionals in hospitals. npj Digit Med. 2023; 6 (1): 1- 14.

[50]

Ijmtst E . AI-driven Healthcare: Predictive Analytics for Disease Diagnosis and Treatment. 2024.

[51]

Pinto-coelho L . How Artificial Intelligence Is Shaping Medical Imaging Technology: A Survey of Innovations and Applications. 2023.

[52]

Mohebi S , Parham M , Sharifirad G , Gharlipour Z . Social Support and Self-Care Behavior Study. IJPER. 2018: 1- 6.

[53]

Maleki Varnosfaderani S , Forouzanfar M . The role of AI in hospitals and clinics: transforming healthcare in the 21st century. Bioengineering. 2024; 11 (4): 1- 38.

[54]

Bohr A , Memarzadeh K . The rise of artificial intelligence in healthcare applications. Artificial Intelligence in Healthcare. 2020: 25- 60.

RIGHTS & PERMISSIONS

The Authors. Publishing services by Elsevier B.V. on behalf of Higher Education Press and KeAi Communications Co. Ltd.

AI Summary AI Mindmap
PDF (2211KB)

258

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/